| Literature DB >> 34039357 |
Jennifer A Kurtz1, Trisha A VanDusseldorp2, J Andrew Doyle3, Jeffrey S Otis3.
Abstract
BACKGROUND: Taurine has become a popular supplement among athletes attempting to improve performance. While the effectiveness of taurine as an ergogenic aid remains controversial, this paper summarizes the current evidence regarding the efficacy of taurine in aerobic and anaerobic performance, metabolic stress, muscle soreness, and recovery.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34039357 PMCID: PMC8152067 DOI: 10.1186/s12970-021-00438-0
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Fig. 1Outline of literature search methodology
Low taurine supplementation studies to date and outcomes
| Author | Participants | Dosage (g) | Timing of Dose | Outcomes |
|---|---|---|---|---|
| Balshaw et al. [ | 8 | 1 | Placebo or a 1000 mg T (capsule) 2 h ingestion period | ↑ 3KTT performance (TA 646.6 ± 52.8 s and PL 658.5 ± 58.2 s) equating to a 1.7% improvement; ↑ Relative oxygen uptake, HR, RPE. No change in blood lactate between conditions |
| Kammerer et al. [ | 14 | 1 | Four beverages drinking 250 ml of one of the following: one with 80 mg caffeine, one with 1000 mg taurine, one with 80 mg caffeine plus 1000 mg taurine, a commercial energy drink (Red Bull®) or a placebo drink 10–15 min prior to a maximal exercise bout | Combination of caffeine (80 mg) + taurine (1000 mg) in an energy drink prior to exercise results in no effects on cardiorespiratory fitness indices (VO2max, HRmax, TTE), strength (RHS and LHS), power (VJ), concentration (Grid) and immediate memory (Digits); No significance of taurine alone on aerobic parameters |
| Page [ | 11 | 0.5 | Taurine (50 mg kg − 1) or placebo (3 mg kg − 1 maltodextrin) 2 h prior to exercise | ↑ TTE by 10% (25.16 min vs. 22.43 min, |
| Rutherford et al. [ | 11 | 1.66 | Consumed a noncaloric sweetened beverage with either 1.66 g of T or nothing added (P) 1 h before exercise | No difference in TT performance between any of the 3 trials; Average carbohydrate and fat oxidation rates were unaffected; 16% ↑ (5 g, ~ 84 kJ; |
| Waldron et al. 2018 [ | 9 | 0.5 | High cadence (90 r/min) + taurine (50 mg/kg body mass); high cadence + placebo (3 mg/kg body mass maltodextrin); low cadence (50 r/min) + taurine; low cadence + placebo 1.5 h prior to exercise | ↓ HR vs. placebo prior to the ramp test; ↑ blood lactate in taurine conditions; ↑ end-test power in taurine conditions |
| Waldron et al. 2019 [ | 12 | 0.5 | Participants were allocated to one of four conditions, separated by 72 h: TTE + taurine; TTE + P; 3MAOT + taurine; 3MAOT + placebo 1.5 h prior to exercise | ↑ CP ( |
| Ward et al. [ | 11 | 1 | Trials were performed two hours after the consumption of either 1000 mg of TAU or placebo (P) | ↓ of TAU on performance; no effect on VO2, lactate, pH, or HCO3 |
| Warnock et al. [ | 7 | 0.5 | C (5 mg/kg/ BM), T (50 mg/kg/ BM), C + T (5 mg/kg/ BM + 50 mg/kg/ BM) or P (5, 49 mg/kg BM) in a gelatin capsule 1 h prior to exercise | ↑ in anerobic performance compared to P, C or C + T, 63 |
↑ = improved performance, ↓ = decreased performance, C creatine, T/TAU taurine, BM bodymass, P placebo, mg/kg milligram per kilogram, TTE time to exhaustion, 3KTT 3-km time trial, RHS right-handed grip strength, LHS left-handed grip strength, VJ vertical jump, RPE rate of perceived exertion, La lactate, CP critical power, 3MAOT 3-min-all-out-test
Chronic- dose taurine supplementation studies to date and outcomes
| Author | Participants | Dosage (g) | Timing of Dose | Outcomes |
|---|---|---|---|---|
| Batitucci 2018 [ | 14 | 3 | 3 g of pure taurine (capsule) every day in the morning before breakfast, during an eight-week period | No changes in energy expenditure or swimming performance; ↑ in plasma taurine and lactate concentrations |
| da Silva et al. [ | 21 | .5 g·kg/BW/day | One capsule per day for a total of 21 days, beginning 14 days before the eccentric protocol and continuing throughout the 7-day postexercise period | ↑ strength levels and thiol total content; ↓ muscle soreness, LAD level, CK activity, and oxidative damage; Antioxidant enzymes and inflammatory markers, and IL-10 were not altered during the recovery period compared with the placebo group |
| Galloway et al. [ | 7 | First part: 1.66 g. Second part: 5 g/day and 6 g/day of placebo | First part: Seven days of oral taurine (1.66 g) supplementation with breakfast and lunch. Second part: cycled for 2 h after 7 days of placebo ingestion (6 g glucose/day) and again following 7 days of T (5 g/day) | No difference in muscle glycogen or other muscle metabolites between conditions; ↑ the appearance of AA following exercise; A 13-fold ↑ increase in plasma taurine concentration; No aerobic effects |
| Lee et al. [ | 24 | 4 | Subjects were randomly divided into 4 groups ( | ↑ TTE (6.9 min or 9.0 min longer) at 75% of VO2max; ↓ serum Pi concentration measured at all-out state (14% ↓) |
| McLeay et al. [ | 10 | 0.1 g/kg/BW; No more than 10 g | Completed 60 eccentric contractions of the biceps brachii muscle at maximal effort. Following this, participants were supplemented with 0.1 g/kg/BW of either taurine or rice flour in capsules; evening. | Significant ↓ in all performance measures from pre- to 24-h post-eccentric exercise ( |
| Ra et al. [ | 29 | 2 | Participants orally consumed 2 g of placebo (lactose) or taurine powder three times a day after meals for 2 weeks before exercise | ↓ DOMS |
| Ra et al. [ | 36 | 2 | Placebo + placebo [placebo], BCAA + placebo, placebo + taurine, and BCAA + taurine [combined]) and given a combination of 3.2 g BCAA (or placebo) and 2.0 g taurine (or placebo), three times a day, for two weeks prior to and three days after eccentric elbow flexor exercises | ↓ exercise-induced DOMS and muscle damage |
| Zhang et al. [ | 11 | 6 | After the first exercise test, the subjects received supplements of a daily dose of 6 g (2 g three times a day) taurine powder for 7 days prior to the second exercise test. After 7-day of taurine supplementation, an identical exhaustive test procedure was repeated at the same time of day | ↓ serum TBARS before exercise (p < 0.05) and resulted in a significantly ↓ DNA migration 24 h after exercise (p < 0.01). Significant ↑ VO2max, ↑ exercise TTE, and ↑ maximal workload in test with taurine supplementation ( |
↑ = improved performance, ↓ = decreased performance, T/TAU taurine, BW bodyweight, P placebo, LAD lactate dehydrogenase, CK creatine kinase, IL-10 interleukin-10, AA amino acids, TTE time to exhaustion, Pi inorganic phosphorus, DOMS delayed onset muscle soreness, TBARS thiobaribituric-acid reative substance
Moderate taurine supplementation studies to date and outcomes
| Author | Participants | Dosage (g) | Timing of Dose | Outcomes |
|---|---|---|---|---|
| Batitucci 2018 [ | 14 | 3 | 3 g of pure taurine (capsule) every day in the morning before breakfast, during an eight-week period | No changes in energy expenditure or swimming performance; ↑ in plasma taurine and lactate concentrations |
| da Silva et al. [ | 21 | .5 g·kg body mass/day (~ 4) | One capsule per day for a total of 21 days, beginning 14 days before the eccentric protocol and continuing throughout the 7-day postexercise period | ↑ strength levels and thiol total content; ↓ muscle soreness, LAD level, CK activity, and oxidative damage; Antioxidant enzymes and inflammatory markers, and IL-10 were not altered during the recovery period compared with the placebo group |
| Galloway [ | 7 | First part: 1.66 g. Second part: 5 g/day and 6 g/day of placebo | First part: Seven days of oral taurine (1.66 g) supplementation with breakfast and lunch. Second part: cycled for 2 h after 7 days of placebo ingestion (6 g glucose/day) and again following 7 days of T (5 g/day) | No difference in muscle glycogen or other muscle metabolites between conditions; ↑ the appearance of amino acids following exercise; A 13-fold ↑ increase in plasma taurine concentration; No aerobic effects |
| Lee et al. [ | 24 | 4 | Subjects were randomly divided into 4 groups ( | ↑ TTE (6.9 min or 9.0 min longer) at 75% of VO2max; ↓ serum Pi concentration measured at all-out state (14% ↓) |
| Lim et al. [ | 14 | ~ 3 | Either cellulose-filled placebo capsules (10 mg/kg body mass; P) or capsules providing 40 mg/kg1 body mass of taurine with 10 mg/kg1 body mass of cellulose (TAU) and drank 250 mL of water one hour prior to testing | In the noncaffeine consumers, taurine resulted in a significant ↓ in maximal voluntary muscle power, ↓ in peak torque, ↓ in first and best power output; taurine ingestion in caffeine-deprived caffeine consumers ↑ maximal voluntary muscle power; no effect on other aspects of contractile performance |
↑ = improved performance, ↓ = decreased performance, T/TAU taurine, P placebo, LAD lactate dehydrogenase, CK creatine kinase, IL-10 interleukin-10, TTE time to exhaustion, Pi = inorganic phosphate
High taurine supplementation studies to date and outcomes
| Author | Participants | Dosage (g) | Timing of Dose | Outcomes |
|---|---|---|---|---|
| De Carvalho et al. [ | 9 | 6 | Athletes received taurine (TAU) or placebo (P) supplementation 120 min before the swimming effort | No effect in swimmer performance; ↑ glycerol plasma levels (8%); ↓ lactic anaerobic system contribution |
| McLeay et al. [ | 10 | 0.1 g/ kg/BW (not exceeding 10 g) | Completed 60 eccentric contractions of the biceps brachii muscle at maximal effort. Following this, participants were supplemented with 0.1 g/kg/BW of either taurine or rice flour in capsules; continued to consume the capsules in the morning and evening. | Significant ↓ in all performance measures from pre- to 24-h post-eccentric exercise ( |
| Milioni et al. [ | 17 | 6 | Placebo (6 g dextrose) or taurine (6 g) supplementation), separated by 1 week, 90 min prior to the exhaustive test | No improvements in high-intensity running performance; unclear effect on maximal accumulated oxygen deficit |
| Ra et al. [ | 29 | 2 | Participants orally consumed 2 g of placebo (lactose) or taurine powder three times a day after meals for 2 weeks before exercise: two sets of maximal eccentric unilateral contractions of the elbow flexor muscle | ↓ DOMS |
| Ra et al. [ | 36 | 2 | Placebo + placebo [placebo], BCAA + placebo, placebo + taurine, and BCAA + taurine [combined]) and given a combination of 3.2 g BCAA (or placebo) and 2 g taurine (or placebo), three times a day, for two weeks prior to and three days after eccentric elbow flexor exercises | ↓ exercise-induced DOMS and muscle damage |
| Zhang et al. [ | 11 | 6 | After the first exercise test, the subjects received supplements of a daily dose of 6 g (2 g three times a day) taurine powder for 7 days prior to the second exercise test. After 7-day of taurine supplementation, an identical exhaustive test procedure was repeated at the same time of day | ↓ serum TBARS before exercise ( |
McLeay [45] dosages ranged from low-to-moderate-to-high; ↑ = improved performance, ↓ = decreased performance, T/TAU taurine, BW bodyweight, P placebo, CK creatine kinase, DOMS delayed onset muscle soreness, BCAA branched chain amino acid, TBARS thiobaribituric-acid reative substance